FMP
May 16, 2024 8:09 PM - Davit Kirakosyan(Last modified: May 17, 2024 2:05 AM)
ZimVie (NASDAQ:ZIMV) shares rose around 2% intra-day today after Needham analysts upgraded the company to Buy from Hold, setting a price target of $20 on the stock.
The analysts explained that channel checks and market commentary indicate the implant market remained stable into the second quarter of 2024. In the short term, cost reduction initiatives are expected to improve margins, even in a flat market.
ZimVie has gained more customers year-over-year, positioning it well for when demand returns, which could further expand margins. The benchmarking analysis suggests that ZimVie has significant long-term margin improvement potential. Considering these factors and the attractive valuation, the analysts believe ZimVie's risk/reward profile is favorable.
Jan 16, 2024 4:18 PM - Samuel Abdelshahid
In the hustle and bustle of the trading world, having a trustworthy laptop is like having a reliable partner by your side. Making well-informed decisions and staying ahead of market trends become second nature with the right device. However, the quest for a budget-friendly trading laptop t...
Jan 21, 2024 4:00 AM - Parth Sanghvi
Introduction: In the world of financial analysis, a profound grasp of essential profitability metrics is vital. This blog delves into three pivotal metrics—ROE (Return on Equity), ROA (Return on Assets), and Net Profit Margin—offering clear insights without unnecessary complexity. Exploring RO...
May 14, 2024 11:41 AM - Sanzhi Kobzhan
A stock's target price, also known as its fair value, is an indication of what a share can cost based on the company’s forecasted financial statements. It is important to know a stock's fair value to find undervalued stocks with great growth potential. Let's consider how investment analysts calculat...